Caplin Point (CAPLIPOINT) | Stock Overview & Key Data
Caplin Point Performance Comparison
Stock Range
Today's Range
Low: ₹2,008.10
High: ₹2,160.00
on August 8, 2025
52 Week Range
Low: ₹1,452.00
High: ₹2,641.00
on August 9, 2024
on December 27, 2024
All-Time High: ₹2,641.00 on December 23, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR146.7B
EPS
70.26
P/E Ratio (TTM)
27.46
Forward P/E
21.09
P/B Ratio
5.29
PEG Ratio
1.59
Div. Yield
0.26%
ROE
20.68%
Beta
0.048
Debt to Equity
0.17
Financial Highlights
Profitability
Gross Margin
59.96%
Operating Margin
30.06%
Profit Margin
27.68%
Returns and Earnings
Return on Assets (TTM)
12.30%
Return on Equity (TTM)
20.68%
EBITDA
INR7.4B
Net Income (TTM)
INR5.4B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR254.89
Quarterly Revenue Growth (YoY)
10.40%
Quarterly Earnings Growth (YoY)
17.30%
Dividend Information
Last 12-Month Dividend
₹5.50
Current Dividend Yield
0.26%
3-Year Average Dividend Yield
0.20%
3-Year Average Annual Dividend
₹4.83
3-Year Total Dividends
₹14.50
Ex-Dividend Date
May 30, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Caplin Point CAPLIPOINT | 146.67B Mid-cap | 6.18% | 4.48% | 11.00% | -0.43% | -15.97% | 40.68% | 166.05% | 285.71% |
| Sun Pharmaceutical SUNPHARMA | 3.84T Large-cap | -2.63% | -5.12% | -10.20% | -8.38% | -16.03% | -8.55% | 73.73% | 198.65% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -7.03% | -14.75% | -0.77% | -0.41% | -2.61% | 22.45% | 58.73% | 91.42% |
| Alembic APLLTD | 184.02B Mid-cap | -2.38% | -6.43% | 3.77% | 5.42% | -10.75% | -15.92% | 45.65% | -8.45% |
| Jubilant Pharmova JUBLPHARMA | 174.95B Mid-cap | -5.02% | -5.59% | 24.87% | 10.08% | 1.88% | 27.78% | 214.12% | 81.50% |
| Natco Pharma NATCOPHARM | 165.27B Mid-cap | -2.50% | -7.83% | 13.12% | -29.19% | -35.03% | -36.97% | 40.23% | 9.43% |
Ownership & Short Interest
Insider Ownership
73.29%
Institutional Ownership
4.60%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
67K
Average 90-Day Volume
81K
Caplin Point Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Caplin Point would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CAPLIPOINT's 52-week high and low?
- In the last 52 weeks, Caplin Point reached a high of ₹2,641.00 (on December 27, 2024) and a low of ₹1,452.00 (on August 9, 2024).
- What is the market cap and P/E ratio for CAPLIPOINT?
- Curious about Caplin Point's size and valuation? Its market capitalization stands at 146.67B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.46, and the forward P/E (looking ahead) is 21.09.
- Does CAPLIPOINT pay dividends? If so, what's the yield?
- Yes, Caplin Point is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.26%, and the company has paid an average of ₹4.83 per share annually over the past 3 years.
- Who are Caplin Point's main competitors or similar companies to consider before investing?
When looking at Caplin Point, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.84T Healthcare Drug Manufacturers - Specialty & Generic -8.55% 73.73% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 22.45% 58.73% Alembic
APLLTD184.02B Healthcare Drug Manufacturers - Specialty & Generic -15.92% 45.65% Jubilant Pharmova
JUBLPHARMA174.95B Healthcare Drug Manufacturers - Specialty & Generic 27.78% 214.12% Natco Pharma
NATCOPHARM165.27B Healthcare Drug Manufacturers - Specialty & Generic -36.97% 40.23% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Caplin Point Laboratories Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Caplin Point's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 20.68%, the Debt to Equity ratio from the most recent quarter is 0.17, and its Gross Profit Margin stands at 59.96%.
- What is the recent revenue and earnings growth for CAPLIPOINT?
- Looking at Caplin Point's growth, its revenue over the trailing twelve months (TTM) was INR19B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.40%, and quarterly earnings saw a YoY growth of 17.30%.
- How much of CAPLIPOINT stock is held by insiders and institutions?
- Wondering who owns Caplin Point stock? Company insiders (like executives and directors) hold about 73.29% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 4.60%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.